Opus Genetics (IRD) Current Taxes (2022 - 2023)
Opus Genetics' (IRD) quarterly Current Taxes came in at $11000.0 in Q3 2023, down 96.51% on a QoQ basis from $315000.0 in Q1 2023.
Opus Genetics (IRD) Current Taxes (2022 - 2023) Analysis & Trends
Opus Genetics (IRD) has 2 years of Current Taxes data on file, last reported at $11000.0 in Q3 2023.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $11000.0 in Q3 2023; TTM through Sep 2023 was $11000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $315000.0, changed N/A from the prior year.
- Current Taxes for Q3 2023 stood at $11000.0, down from $315000.0 in the prior quarter.
- Over the last five years, Current Taxes for IRD reached as high as $315000.0 in Q4 2022 and fell as low as $11000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 11,000.00 |
| Mar 31, 2023 | 315,000.00 |
| Dec 31, 2022 | 315,000.00 |